209 related articles for article (PubMed ID: 6311559)
1. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.
Konno T; Maeda H; Iwai K; Tashiro S; Maki S; Morinaga T; Mochinaga M; Hiraoka T; Yokoyama I
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1053-65. PubMed ID: 6311559
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial injection of an oily antineoplastic agent in hepatic cancer].
Konno T; Tashiro S; Maeda H; Iwai K; Ogata K; Mochinaga M; Uemura K; Ishimaru S; Miyauchi Y; Yokoyama I
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):351-7. PubMed ID: 6309086
[TBL] [Abstract][Full Text] [Related]
3. [Arterial administration of high molecular weight antitumor agent, SMANCS dissolved in ethiodol for various malignant solid tumors].
Konno T; Iwai K; Maki S; Uchida M; Ogata K; Tashiro S; Miyauchi Y; Yokoyama I; Maeda H
Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1845-51. PubMed ID: 6323597
[No Abstract] [Full Text] [Related]
4. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
Konno T; Maeda H; Yokoyama I; Iwai K; Ogata K; Tashiro S; Uemura K; Mochinaga M; Watanabe E; Nakakuma K; Morinaga T; Miyauchi Y
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2005-15. PubMed ID: 6307179
[TBL] [Abstract][Full Text] [Related]
5. [CT image of the liver cancer after administration of SMANCS/lipiodol].
Maki S; Konno T; Iwai K; Tashiro S; Otsuka N; Yamasaki K; Mizutani J; Miyauchi Y; Maeda H; Yokoyama I
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1603-10. PubMed ID: 3015036
[TBL] [Abstract][Full Text] [Related]
6. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].
Maeda H; Konno T; Iwai K; Maki S; Tashiro S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.
Tashiro S; Maeda H
Jpn J Med; 1985 Feb; 24(1):79-80. PubMed ID: 2987585
[No Abstract] [Full Text] [Related]
8. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N
Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351
[TBL] [Abstract][Full Text] [Related]
9. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
10. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
11. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
12. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
[TBL] [Abstract][Full Text] [Related]
13. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
Maki S; Konno T; Iwai K; Uchida M; Tashiro S; Miyauchi Y; Maeda H
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1443-9. PubMed ID: 6097616
[No Abstract] [Full Text] [Related]
14. [Arterial infusion chemotherapy with SMANCS].
Nekohashi T; Maruno J; Sanjou A; Toda G
Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
[No Abstract] [Full Text] [Related]
15. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
[TBL] [Abstract][Full Text] [Related]
16. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
17. A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.
Seymour LW; Olliff SP; Poole CJ; De Takats PG; Orme R; Ferry DR; Maeda H; Konno T; Kerr DJ
Int J Oncol; 1998 Jun; 12(6):1217-23. PubMed ID: 9592177
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
Okusaka T; Okada S; Ishii H; Ikeda M; Nakasuka H; Nagahama H; Iwata R; Furukawa H; Takayasu K; Nakanishi Y; Sakamoto M; Hirohashi S; Yoshimori M
Oncology; 1998; 55(4):276-83. PubMed ID: 9663415
[TBL] [Abstract][Full Text] [Related]
19. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T; Maeda H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
Tsuchiya K; Uchida T; Kobayashi M; Maeda H; Konno T; Yamanaka H
Urology; 2000 Apr; 55(4):495-500. PubMed ID: 10736490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
